Asymmetric dimethylarginine and coronary collateral vessel development.

@article{Kocaman2008AsymmetricDA,
  title={Asymmetric dimethylarginine and coronary collateral vessel development.},
  author={Sinan Altan Kocaman and Asife Şahinarslan and Gursel Biberoğlu and Alev Hasanoğlu and Ahmet Akyel and Timur Timurkaynak and Atiye Çengel},
  journal={Coronary artery disease},
  year={2008},
  volume={19 7},
  pages={469-74}
}
INTRODUCTION Nitric oxide (NO) plays a major role in collateral vessel development. Asymmetric dimethylarginine (ADMA) that is an endogenous inhibitor of NO synthesis may impair the effective coronary collateral vessel development. The aim of this study was to evaluate the relationship between plasma ADMA level and coronary collateral vessel development. METHODS The patients with a greater than or equal to 95% obstruction in at least one epicardial coronary artery were included in the study… CONTINUE READING